S. Wera et al., CYCLOSPORINE-A, RAPAMYCIN AND FK506 DECREASE PROLACTIN-RELEASE FROM RAT PITUITARY-CELLS IN PRIMARY CULTURE, Endocrine research, 21(3), 1995, pp. 623-633
It is at present well established that prolactin exerts a non-specific
immunoactivating function. In this work we tested whether the immunos
uppressant drugs cyclosporin A, FK506 and rapamycin influence prolacti
n release from rat pituitary cells in primary culture. The tested drug
s had no effect on the prolactin release measured during a 2h incubati
on period, indicating that they do not influence the secretion of prol
actin from intracellular stores into the culture medium. During longer
incubation times (48h), however, prolactin release was diminished to
56% +/- 18 (10 mu M cyclosporin A), 64% +/- 14 (1 mu M rapamycin) or 6
4% +/- 7 (1 mu M FK5O6), suggesting an effect on prolactin production.
At these drug concentrations no toxic effects were observed. The data
indicate that inhibition of pituitary prolactin synthesis might contr
ibute to the immunosuppressant action of cyclosporin A rapamycin and F
K506.